相关实验视频

Updated: Jun 11, 2025

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

[卵巢黑色素瘤:发展的分子和遗传机制和治疗方法]

M V Zhilnikova^1,2, O S Troitskaya¹, D D Novak¹

¹Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090 Russia.

Molekuliarnaia biologiia

|October 2, 2024

概括

卵巢黑色素瘤 (UM) 是一种攻击性的眼睛癌. 像GNAQ/GNA11这样的基因突变驱动UM. 预测转移风险是治疗的关键,但缺乏全身治疗.

科学领域:

眼科医生眼科眼科
在瘤学瘤学.
分子生物学分子生物学

背景情况:

卵巢黑色素瘤 (UM) 是一种罕见但具有攻击性的神经外皮眼瘤.
它占所有黑色素瘤病例的5%,并且具有转移的高风险.
UM的分子机制与皮肤黑色素瘤不同,GNAQ/GNA11突变普遍存在.

研究的目的:

审查毛膜黑色素瘤 (UM) 致癌的分子机制.
讨论与转移性UM (MUM) 相关的遗传突变.
探索目前和新兴的MUM治疗策略.

主要方法:

关于UM分子生物学和遗传学的科学文献的综述.
对基因表达和突变面板进行基因表达和突变面板分析,以预测转移风险.
在临床试验中检查向疗法和免疫疗法.

主要成果:

在90%的UM患者中发现了GNAQ和GNA11基因的激活突变.
在BAP1,EIF1AX,GNA11,GNAQ和SF3B1中的突变与转移性UM有关.
结合基因表达和突变面板,以及瘤大小,有效预测转移风险.

结论:

了解UM分子驱动因素,特别是GNAQ/GNA11突变,至关重要.
准确的转移风险预测指导UM患者的治疗和随访.
虽然MUM的全身疗法有限,但向药物和免疫疗法与表观遗传调节策略一起显示出希望.

关键词:

在 BAP1 中, BAP1 是 BAP1 的前身.在GNAQ/11上驱动器突变驱动器突变表观遗传的目标是表观遗传的目标.黑色素体 (Melanosomes) 是一种有色素体.这样,你就有了TEBENTAFUSP.阴膜性黑色素瘤是什么

更多相关视频

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development

Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development

Published on: September 4, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...